Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ZFY///ZFX |
| Upstream (Parents) |
|---|
| (<<) SOCS6 → ZFY///ZFX |
| (<<) KIAA0090 → ZFY///ZFX |
| (<<) NEK9 → ZFY///ZFX |
| (<<) FAM108B1 → ZFY///ZFX |
| Downstream (Children) |
|---|
| ZFY///ZFX → SRSF5 (>>) |
| ZFY///ZFX → SOCS6 (>>) |
| ZFY///ZFX → RAP2B (>>) |
| ZFY///ZFX → PAK7 (>>) |
| ZFY///ZFX → EXOG (>>) |
| ZFY///ZFX → PCDH11Y///PCDH11X (>>) |
| ZFY///ZFX → LRRC68 (>>) |
| ZFY///ZFX → CACNG2 (>>) |
| ZFY///ZFX → GDAP1 (>>) |
| ZFY///ZFX → OR10C1 (>>) |
| ZFY///ZFX → SPN (>>) |
| ZFY///ZFX → SMEK1 (>>) |
| ZFY///ZFX → SS18 (>>) |
| ZFY///ZFX → CDKAL1 (>>) |
| ZFY///ZFX → ZNF238 (>>) |
| ZFY///ZFX → TIMM50 (>>) |
| ZFY///ZFX → FRS2 (>>) |
| ZFY///ZFX → KIAA0090 (>>) |
| ZFY///ZFX → NEK9 (>>) |
| ZFY///ZFX → VPS33A (>>) |
| ZFY///ZFX → FNTB (>>) |
| ZFY///ZFX → CHM (>>) |
| ZFY///ZFX → FAM108B1 (>>) |
| ZFY///ZFX → DAPP1 (>>) |
| ZFY///ZFX → STAM2 (>>) |
| ZFY///ZFX → C10orf28 (>>) |
| ZFY///ZFX → TNXB///ATF6B (>>) |
